NOBIVAC Feline 3-HCP

The only USDA-approved, 3-year core feline vaccine for rhinotracheitis, calicivirus, and panleukopenia. Shown to be effective for vaccination of healthy cats 8 weeks of age or older against feline rhinotracheitis, calici, and panleukopenia viruses. Duration of immunity is at least 3 years.

• The American Association of Feline Practitioners (AAFP) has recommended 3-year vaccination intervals for core antigens such as HCP75
• 100% protection against disease associated with virulent feline panleukopenia virus (FPV) challenge73
• 100% protection against oral ulcerations associated with feline calicivirus (FCV) infection73
• Non-adjuvanted formulation
• Optimal choice for healthy indoor cats

Indications:

Shown to be effective for vaccination of healthy cats 8 weeks of age or older against feline rhinotracheitis, calici, and panleukopenia viruses. Duration of immunity is at least 3 years

NOBIVAC® FELINE 3-HCP IS A SAFE CHOICE

• Less likely to produce local and systemic reactions
• Extended duration of immunity (DOI) to minimize the number of injections
• Nobivac® Feline 3-HCP is the only USDA-approved, 3-year vaccine for rhinotracheitis, calicivirus, and panleukopenia
  • 3-year DOI proven in challenge studies
• American Association of Feline Practitioners (AAFP) has recommended 3-year vaccination intervals for core antigens such as HCP

ADMINISTRATION AND DOSAGE

• Subcutaneous injection
• Initial 1 mL dose administered at 8 weeks or older
• Booster injection administered 3 to 4 weeks following the initial vaccination
• Cats 12 weeks of age or older should receive two 1 mL doses 3 to 4 weeks apart
• Revaccination with 1 dose is recommended every 3 years
• Available in a 25 x 1 mL dose presentation

Safety Data Sheet

Manufacturer Information/Label